Tag Archives: TPOXX

NIH Launches Phase 3 Trial Of Monkeypox Med TPOXX

From the National Institutes of Health: A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. Study investigators aim to enroll more than 500 people from clinical research sites nationwide. Interested volunteers can visit the ACTG website for more information. The trial is sponsored …

Read More »

HHS To Distribute 1.8M MPX Vaccine Doses On Monday

Via press release from the White House: Today, HHS is announcing that it has accelerated Phase 4 of its National Vaccine Strategy and will be making an additional 1.8 million doses available for ordering starting Monday, August 22. Jurisdictions that are adopting the intradermal administration of vaccine and have used 90% of their current supply of vaccine will be able …

Read More »

Feds Pressed To Ease Access To Monkeypox Med

Gothamist reports: Advocates and lawmakers are calling for the Biden administration to remove barriers to access for a promising medication called tecovirimat, or TPOXX, as New York’s monkeypox outbreak worsens. So far, the U.S. Food and Drug Administration has only approved the medication for the treatment of smallpox — though some early studies show TPOXX can help against monkeypox, too. …

Read More »